読み込み中
NASDAQHealthcareMedical - Diagnostics & Research
最新データ
$98.09
+$2.68 · +2.81%
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
前日終値
$98.09
+$2.68 · +2.81%
日中の時刻はETです。市場データは遅延する場合があります。
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
日中レンジ
現在 $98.09
52週レンジ
現在 $98.09
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
89
大幅な割安
センチメント
51
まちまち
リスク
38
中程度のリスク
モメンタム
75
上昇基調
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
日中レンジ
現在 $98.09
52週レンジ
現在 $98.09
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 |
|---|---|---|---|
| 売上高 | 3.05億 USD | 1.53億 USD | 7172.9万 USD |
| 売上原価 | 9665.4万 USD | 7166.7万 USD | 5442.1万 USD |
| 粗利益 | 2.08億 USD | 8091.5万 USD | 1730.8万 USD |
| 研究開発 | 4938.4万 USD | 3659.6万 USD | 2241.4万 USD |
| 販売・一般管理 | 1.43億 USD | 9146.5万 USD | 6438.9万 USD |
| 営業費用 | 1.92億 USD | 1.28億 USD | 8680.3万 USD |
| 受取利息 | 775万 USD | 581.9万 USD | 345.6万 USD |
| 支払利息 | 9.5万 USD | 238.6万 USD | 327.2万 USD |
| 減価償却費と償却費 | 1190.7万 USD | 1168.8万 USD | 646.3万 USD |
| 営業利益 | 1602.3万 USD | −4714.6万 USD | −6949.5万 USD |
| 純利益 | 745.4万 USD | −4157万 USD | −8268.3万 USD |
会社概要が更新されました 2026年10月11日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$126
上昇余地（28.45%）この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI6580.92万0.00%2.3兆 USD0.03%$381.94+0.63%
Vanguard Morningstar Small-Cap ETFVB4751.72万0.03%1853億 USD0.03%$289.48+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR1509.95万0.02%682億 USD0.05%$234.43+0.22%
Vanguard Morningstar Small-Cap Growth ETFVBK1361.13万0.03%447億 USD0.05%$344.74+1.22%
Schwab U.S. Small-Cap ETFSCHA1119.5万0.05%218.24億 USD0.03%$32.79+0.40%
F/M Emerald Life Sciences Innovation ETFLFSC529.68万4.49%1.18億 USD0.79%$42.6071+2.24%
Vanguard Extended Market ETFVXF477.2万0.00%954億 USD0.05%$235+0.80%
iShares U.S. Healthcare Providers ETFIHF370.49万0.28%13.54億 USD0.37%$56.76+1.74%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRVanguard Morningstar Small-Cap Growth ETFVBKSchwab U.S. Small-Cap ETFSCHAF/M Emerald Life Sciences Innovation ETFLFSCVanguard Extended Market ETFVXFiShares U.S. Healthcare Providers ETFIHFAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
